Societies Issue Joint Guidance for Osteoporosis Management During the COVID-19 Pandemic
A coalition of experts representing multiple medical societies issued guidance on the management of osteoporosis during the COVID-19 pandemic.
A coalition of experts representing multiple medical societies issued guidance on the management of osteoporosis during the COVID-19 pandemic.
The Endocrine Society has issued an update to the organization’s 2019 clinical practice guideline on pharmacologic management of osteoporosis to include romosozumab.